Synergy Pharmaceuticals Inc (NASDAQ:SGYP) impressed Rodman & Renshaw analyst Ram Selvaraju with the announcement yesterday evening that the biotech has attained “a milestone …
In a research report published Monday, H.C.
Inovio Pharmaceuticals Inc (NASDAQ:INO) released third-quarter financial earnings and a clinical progress update on the firm’s pipeline on Wednesday, November 9th. H.
On Sunday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that the FDA has placed a clinical hold on its prospective Phase 3 pivotal trial evaluating …
H.C.
Yesterday, DURECT Corporation’s (NASDAQ:DRRX) licensee Pain Therapeutics announced that it had received a complete response letter (CRL) from the FDA for the resubmitted …
As of the end of August 2016, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) competitor Allergan has changed the language in its product label for Linzess, …
Yesterday, Biocept Inc (NASDAQ:BIOC) announced news of solidifying a new agreement with Teneovita Medical Innovations for a full distribution range of liquid biopsy testing …
Inovio Pharmaceuticals Inc (NASDAQ:INO) posted second-quarter financial results on Monday. With pipeline drug approval within reach, a new Phase 3 study starting soon, …
On Monday, biotech firm Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported second-quarter financial results as well as declared completion of over 95% for patient enrollment …
